SCALZO RICHARD WILLIAM (Chief Financial Officer) received a stock award from CRESCENT BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 12/17/2025ACC: 0001628280-25-057681
Officer· Chief Financial Officer
Since Jun 2025
+77.11K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
77.11K acquired
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+14.42K
Price / share
—
Trade value
—
% of position
New position
12/15/2025
0.00→14.42K
Ordinary Shares
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
34.7%
12/15/2025
14.42K→19.42K
Total
Net shares
+19.42K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/15/2025 | A · Award | +14.42K | — | — | New position | 0.00 | 14.42K |
| Ordinary Shares Direct | 12/15/2025 | A · Award | +5K | — | — | 34.7% | 14.42K | 19.42K |
| Total | +19.42K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
57.69K shares
Shares
+57.69K
Strike price
13.21
Held after
57.69K
Exercisable
—
12/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares57.69K shares | 12/15/2025 | A · Award | +57.69K | 13.21 | — | 57.69K |